MPM Oncology Impact Management »

Crinetics Pharmaceuticals In shares owned by MPM Oncology Impact Management

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by MPM Oncology Impact Management from 13F filings

Historical chart of MPM Oncology Impact Management investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by MPM Oncology Impact Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $14M 479k 29.74
2023-06-30 $8.6M 479k 18.02
2023-03-31 $5.8M 360k 16.06
2022-12-31 $6.8M 372k 18.30
2022-09-30 $7.2M 365k 19.64
2022-06-30 $6.8M 367k 18.65
2022-03-31 $8.0M 367k 21.95
2021-12-31 $11M 380k 28.41
2021-09-30 $6.3M 298k 21.05